Blue Bell, PA, United States of America

Michael Dennis Feldkamp

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.1

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Dennis Feldkamp: Innovator in Biotech

Introduction

Michael Dennis Feldkamp is a notable inventor based in Blue Bell, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of proteins and antigen binding domains. With a total of 2 patents, Feldkamp's work has the potential to impact various medical applications.

Latest Patents

Feldkamp's latest patents include "Proteins comprising CD3 antigen binding domains and uses thereof." This patent discloses antigen binding domains that specifically bind to the cluster of differentiation 3 (CD3) protein, including those that bind to CD3ε. The patent also covers polynucleotides encoding these domains, vectors, host cells, and methods for making and using them. Another significant patent is "Materials and methods for improved single chain variable fragments," which outlines innovative materials and methods for enhancing single chain variable fragments.

Career Highlights

Feldkamp is currently employed at Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work at this leading biotech company allows him to collaborate with other experts in the field and contribute to groundbreaking innovations.

Collaborations

Some of his notable coworkers include Jinquan Luo and Lauren Boucher, who work alongside him in various projects at Janssen Biotech, Inc. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs.

Conclusion

Michael Dennis Feldkamp is a distinguished inventor whose work in biotechnology is paving the way for advancements in medical science. His patents reflect a commitment to innovation and a desire to improve healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…